Linping Cao

546 total citations
25 papers, 379 citations indexed

About

Linping Cao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Linping Cao has authored 25 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Linping Cao's work include Pancreatic and Hepatic Oncology Research (5 papers), Per- and polyfluoroalkyl substances research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Linping Cao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Per- and polyfluoroalkyl substances research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Linping Cao collaborates with scholars based in China and Madagascar. Linping Cao's co-authors include Shusen Zheng, Jian Wu, Yuanchen Chen, Zhen Lv, Hangbiao Jin, Chaofeng Ding, Haiyang Xie, Chengli Du, Lin Zhou and Kwabena Gyabaah Owusu-Ansah and has published in prestigious journals such as Environmental Science & Technology, Hepatology and Journal of Hazardous Materials.

In The Last Decade

Linping Cao

22 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linping Cao China 11 150 129 71 68 49 25 379
Yixia Yang China 14 306 2.0× 166 1.3× 88 1.2× 40 0.6× 25 0.5× 34 633
Benedicte Stavik Norway 14 165 1.1× 141 1.1× 45 0.6× 15 0.2× 34 0.7× 31 574
Jiajin Wu China 10 136 0.9× 101 0.8× 53 0.7× 44 0.6× 85 1.7× 23 295
Weiping Xu China 10 120 0.8× 52 0.4× 32 0.5× 63 0.9× 19 0.4× 22 362
Fei Luo China 14 170 1.1× 120 0.9× 75 1.1× 131 1.9× 69 1.4× 29 576
Dhiral Phadke United States 10 295 2.0× 78 0.6× 111 1.6× 60 0.9× 24 0.5× 25 473
Lu Wu China 12 181 1.2× 91 0.7× 67 0.9× 20 0.3× 56 1.1× 22 336
Kazuyuki Okamura Japan 11 147 1.0× 36 0.3× 44 0.6× 54 0.8× 23 0.5× 24 356
Doaa Hashad Egypt 12 185 1.2× 157 1.2× 58 0.8× 14 0.2× 39 0.8× 33 393

Countries citing papers authored by Linping Cao

Since Specialization
Citations

This map shows the geographic impact of Linping Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linping Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linping Cao more than expected).

Fields of papers citing papers by Linping Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linping Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linping Cao. The network helps show where Linping Cao may publish in the future.

Co-authorship network of co-authors of Linping Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Linping Cao. A scholar is included among the top collaborators of Linping Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linping Cao. Linping Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xuanyu, Linping Cao, Zhe Yang, et al.. (2025). Post-Transplant Hepatitis B Virus Reactivation and Survival in Hepatocellular Carcinoma Patients with Alcoholic Liver Disease. Engineering. 49. 304–313.
2.
3.
Li, Jun‐Xu, Fangfang Ren, Linping Cao, Hangbiao Jin, & Yang Li. (2025). Transplacental transfer of p-phenylenediamine antioxidants: Insights from human gestational exposure and an optimized BeWo cell monolayer model. Journal of Hazardous Materials. 495. 139004–139004. 1 indexed citations
4.
Zhang, Weichen, Hangbiao Jin, Yuanchen Chen, et al.. (2024). 6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer. Journal of Hazardous Materials. 474. 134790–134790. 2 indexed citations
5.
Zhang, Weichen, Tingting Pan, Tong Wu, et al.. (2024). PFOS and Its Commercial Alternative, 6:2 Cl-PFESA, Induce Multidrug Resistance in Pancreatic Cancer. Environmental Science & Technology. 58(50). 22027–22038. 2 indexed citations
6.
Zhang, Weichen, Xiaojun Guo, Cheng Zhang, et al.. (2024). Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization. Hepatobiliary & pancreatic diseases international. 24(2). 157–163.
7.
Jin, Hangbiao, Yuanchen Chen, Yifan Jiang, et al.. (2024). Evidence of promoting effects of 6:2 Cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health?. Environment International. 186. 108582–108582. 23 indexed citations
8.
Chen, Kangjie, et al.. (2024). Duodenal papilla radiomics-based prediction model for post-ERCP pancreatitis using machine learning: a retrospective multicohort study. Gastrointestinal Endoscopy. 100(4). 691–702.e9. 5 indexed citations
9.
Wang, Xiaoyan, Hangbiao Jin, Yuanchen Chen, et al.. (2023). Environment relevant exposure of perfluorooctanoic acid accelerates the growth of hepatocellular carcinoma cells through mammalian target of rapamycin (mTOR) signal pathway. Environmental Pollution. 341. 122910–122910. 10 indexed citations
10.
Wang, Qing, Kewei Liang, Haitao Zhang, et al.. (2023). Deep learning nomogram for preoperative distinction between Xanthogranulomatous cholecystitis and gallbladder carcinoma: A novel approach for surgical decision. Computers in Biology and Medicine. 168. 107786–107786. 7 indexed citations
11.
Cao, Linping, et al.. (2022). Per-/polyfluoroalkyl substance concentrations in human serum and their associations with liver cancer. Chemosphere. 296. 134083–134083. 46 indexed citations
12.
Cao, Linping, et al.. (2021). Ileo-ileal intussusception and gastrointestinal bleeding caused by incidental heterotopic pancreas: four case reports. Annals of Translational Medicine. 9(3). 272–272. 3 indexed citations
13.
Liu, Xi, et al.. (2020). Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: A case report and literature review. Clinics and Research in Hepatology and Gastroenterology. 45(1). 101457–101457. 9 indexed citations
14.
Cao, Linping, Xi Liu, Yufu Ye, et al.. (2020). Metastatic renal cell carcinoma to the pancreas and subcutaneous tissue 10 years after radical nephrectomy: a case report. Journal of Medical Case Reports. 14(1). 36–36. 5 indexed citations
15.
Weng, Xiaoyu, Jingbang Wu, Zhen Lv, et al.. (2019). Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5. EBioMedicine. 44. 225–236. 24 indexed citations
16.
Cao, Linping, Lingfeng Zhou, Yufu Ye, et al.. (2019). Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience. World Journal of Surgical Oncology. 17(1). 183–183. 17 indexed citations
17.
Cao, Linping, et al.. (2019). A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile. Medicine. 98(28). e16245–e16245. 5 indexed citations
18.
Chen, Diyu, Linping Cao, Xiaode Feng, et al.. (2019). Spontaneous rupture of solid pseudopapillary tumor of pancreas. Medicine. 98(44). e17554–e17554. 11 indexed citations
19.
Tang, Xiaofeng, Zheyue Shu, Xiaodong Shen, et al.. (2018). MicroRNA‑223 promotes hepatocellular carcinoma cell resistance to sorafenib by targeting FBW7. Oncology Reports. 41(2). 1231–1237. 14 indexed citations
20.
Du, Chengli, Zhen Lv, Linping Cao, et al.. (2014). MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. Journal of Translational Medicine. 12(1). 259–259. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yixia Yang Breakdown of academic impact, for papers by Benedicte Stavik Breakdown of academic impact, for papers by Jiajin Wu Breakdown of academic impact, for papers by Weiping Xu Breakdown of academic impact, for papers by Fei Luo Breakdown of academic impact, for papers by Dhiral Phadke Breakdown of academic impact, for papers by Lu Wu Breakdown of academic impact, for papers by Kazuyuki Okamura Breakdown of academic impact, for papers by Doaa Hashad
Rankless by CCL
2026